I would add a couple of Qs:
1. What happened to the interest from Europe for AML trials?
2. Are we designing AML trials also to measure cardio protection and FTO inhibition?
3. At what point do we want to trial cardio protection in Europe/ US? Phase 2?
Thanks.
- Forums
- ASX - By Stock
- RAC
- Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220, page-25
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.89 |
Change
0.120(6.80%) |
Mkt cap ! $321.0M |
Open | High | Low | Value | Volume |
$1.78 | $1.93 | $1.78 | $563.4K | 302.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 108 | $1.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.90 | 4926 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 108 | 1.880 |
2 | 8000 | 1.855 |
4 | 12250 | 1.850 |
2 | 32500 | 1.840 |
1 | 2500 | 1.835 |
Price($) | Vol. | No. |
---|---|---|
1.900 | 4926 | 1 |
1.920 | 2311 | 1 |
1.930 | 275 | 1 |
1.935 | 10400 | 1 |
1.940 | 5260 | 1 |
Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |